EUA

In a clinical trial, casirivimab and imdevimab, administered together, were shown to reduce COVID-19-related hospitalisation or…

The US FDA said that it would hold a meeting of the advisory committee on December 10 at which members would discuss the vaccine

Baricitinib is an FDA-approved drug to treat rheumatoid arthritis

Bamlanivimab allocations to states and territories will be based on their number of hospitalised COVID-19 patients and the number…

 AbCellera’s partner, Eli Lilly and Company, will supply the US government with 300,000 doses of bamlanivimab for allocation to…

The company intends to file for EUA in the first quarter of 2021 either following interim data at 75 per cent or at study…

Unlike convalescent plasma, hIVIG is a plasma product that is a standardised and concentrated mixture of polyclonal antibodies…

If the interim readout is deemed by the independent safety committee as positive with 70 or 80 or 90 per cent efficacy, we will…

FDA Commissioner also said that it is not a blanket approval and will be subject to benefits outweighing the risks

The expansion is supported by the FDA’s analysis of additional data from two randomised, controlled clinical trials that included…